Best OTC

PROTEONOMIX, INC. (OTC.BB:PROT), a biotechnology company focused on developing therapeutics based upon the use of human cells and their derivatives, reported recently that Mr. Michael Cohen, Chairman and CEO, is scheduling a multi-city European road trip to create additional awareness of the Proteonomix, Inc. investment opportunity to institutional investors.

Scheduled for early October, Mr. Cohen will discuss with sophisticated investors the recent contract to establish a joint venture with a group of investors that will establish a new stem cell treatment and research facility in the United Arab Emirates (U.A.E.). In addition, Mr. Cohen will discuss the opportunity to set up additional joint ventures in other countries using the U.A.E. arrangement as a model.

The recent contract calls for the joint venture partner to invest $5 million on or before September 10, 2010 in a Joint Venture company, XGEN Medical LLC. (”XGen”), a Nevis Island limited liability company.

“Proteonomix has made great strides recently,” stated Mr. Cohen, “and we have been contacted by several European entities that have requested additional information about our proprietary stem cell activities. In recognition of the interest in Europe and the potential for additional joint venture agreements in various European countries, we recognize that it is propitious to meet with a number of the European institutional investors both to educate them on the intrinsic value of Proteonomix shares and garner interest in strategic relationships.”

Generex Biotechnology Corporation (Nasdaq:GNBT) reports the engagement of Dr. George E. Peoples, Jr., M.D., F.A.C.S. as a consultant to the Company in respect of the on-going clinical and regulatory work of Antigen Express, Inc., the Company’s wholly-owned subsidiary, in respect of the proprietary Antigen Express AE37 immunotherapeutic breast cancer vaccine, presently in a Phase II clinical trial at The Henry M. Jackson Foundation for the Advancement of Military Medicine.

Dr. Peoples is presently the Chief of Surgical Oncology at Brooke Army Medical Center in Houston, TX, a Professor of Surgery and the Director & Principal Investigator of the Cancer Vaccine Development Program at Uniformed Services University of the Health Sciences in Bethesda, MD, and the Deputy Director of the United States Military Cancer Institute. Dr. Peoples is a graduate of Johns Hopkins University School of Medicine.

During his career, Dr. Peoples has authored over 100 papers in peer-reviewed journals and conducted numerous clinical studies of peptide vaccines. As such, he is uniquely qualified to help guide the success of AE37. Pursuant to the consultancy arrangement, Dr. Peoples will supervise the on-going Phase II clinical trial of the Company’s breast cancer vaccine, provide advice and assistance to the Company in respect of the design and implementation of a Phase III trial of the vaccine, and liaise with the Food and Drug Administration regarding the clinical and regulatory development of the vaccine. “We are very fortunate to have the assistance of Dr. Peoples in the development of AE37,” said Dr. Eric von Hofe, President of Antigen Express. “There are few people with his experience and insight into the development of active immunotherapy for cancer.”

Generex is engaged in the research, development and commercialization of drug delivery systems and technologies. Generex has developed a proprietary platform technology for the delivery of drugs into the human body through the oral cavity (with no deposit in the lungs).

The Alberto Culver Company (NYSE:ACV) is an innovative leader in consumer products in key markets around the world. ACV’s product portfolio builds from a strong core of beauty and personal care brands and includes a group of innovative household products.

Millions of consumers daily turn to TRESemmé, Nexxus, Alberto VO5, Soft & Beautiful, Motions, Just For Me, Consort and TCB brands to give their hair the style they desire. St. Ives and Noxzema skin care products are brands consumers trust for cleansing, moisturizing and protection.

The St. Ives Swiss Formula brand was among the earliest pioneers in creating a broad skin care line built around botanicals and other natural ingredients. Today, St. Ives continues to innovate and discover new natural solutions for skin care needs in three key areas: cleansers, body washes and body lotions and moisturizers. St. Ives Apricot Scrub is one of the leading products in the facial cleansing category. The line has grown to include a range of products to meet specific skin needs and the line continues to expand with the new St. Ives Elements line which includes an olive scrub and cleanser, a warming scrub, a microdermabrasion product and an SPF protective cleanser.

During the economic crisis the personal products industry was forced to focus their attention on price reduction in order to move products. The industry fared somewhat better than other non essential goods but brands and high price items suffered. Recently released quarterly earnings have generally shown improvement in the industry, reflecting the upward trend in the economy and a moderate increase in employment. Alberto-Culver Co. saw its profit jump 69% back in July.

THIS IS NOT A RECOMMENDATION TO BUY OR SELL ANY SECURITY!

Disclaimer: Never invest in any stock featured on our site or emails unless you can afford to lose your entire investment. BestOtc.com publisher and its affiliates and contractors are not registered investment advisers or broker/dealers.Our disclaimer ( http://bestotc.com/disclaimer) is to be read and fully understood before using our site, reading our newsletter or joining our email list. Release of Liability: Through use of this website viewing or using, you agree to hold BestOTC.com report and Crown Equity Holdings Inc. CRWE, its operators, shareholders, employees and/or contractors harmless and to completely release them from any and all liability due to any and all loss (monetary or otherwise), damages (monetary or otherwise) that you may occur. Rule 17B requires disclosure of payment for investor relations. Crown Equity Holdings Inc. (CRWE.OB) is a newswire as well as an IR and PR firm. Crown Equity Holdings Inc. (CRWE.OB), in some cases, provides media advertising and public awareness for both public and private companies, as well as disseminating news. As such, in some cases, when Crown Equity Holdings Inc. (CRWE.OB) advertises for a particular client, Crown Equity Holdings Inc. (CRWE.OB) charges an advertising fee which it must disclose under 17B. The fee may be in cash, in free trading stock or in restricted stock. Crown Equity Holdings Inc. (CRWE.OB), if paid in stock, can and may sell those securities during the advertising period. Crown Equity Holdings Inc. (CRWE.OB) has received twenty five thousand dollars in cash and seventy five thousand free trading shares from a third party (Bishop Equity Partners) for (30) days of advertising for Muscle Pharm Corp. (MSLP.OB). Crown Equity Holdings Inc. (CRWE.OB) has received twenty thousand dollars in cash and twenty thousand dollars in free trading share from a third party (Swiss Financial Report) for (30) days of advertisement services for Proteonomix, Inc. (PROT.OB).

Reported by: Anza CRWE Newswire Middle East correspondent.

The British Petroleum oil spill also known as Deep Water Horizon, in the Gulf of Mexico is the largest marine oil spill in the history of the petroleum industry. Around 4.9 million barrels leaked from the time the well ruptured a mile below sea level on April 20, 2010. The leak was followed by an explosion which killed 11 workers. It took almost three months to be contained and the well was finally capped on July 15 with only 800,000 barrels captured during a containment operation.

As BP moves towards shutting down the well for good, it was estimated that the well kept on oozing some 62,000 barrels per day for 87 days before being capped. This leakage is much more than that of the original estimates. BP will be fined under the Clean Water Act which allows the US government to seek civil penalties for illegal discharges of oil. According to the law, BP could be fined within the range of $1100 to $4300 per barrel leaked into the gulf.

British Oil Giant British Petroleum has revealed on Friday, Sept 03 that it has already spent $8 Billion to battle the oil spill disaster. The British energy giant has forecasted that the world’s worst oil spill will cost the group a total of about $32.2 billion.

US President Barack Obama placed the blame squarely on the petroleum giant and the US government is conducting a criminal investigation into the incident, BP is hoping to shift some of the blame on its contractors.

The contractors include Transocean which leased the Deep Water Horizon rig and Halliburton which cemented the well.

BP has promised to cover the costs of the cleaning and compensations for residents, hit hard by a fishing ban. It also vowed to take care of the local tourist industry damaged by this deep sea accident.

********************************************************************

The Views and Opinions Expressed by the author are his or her opinions only and do not necessarily reflect those of this Web-Site or its agents, affiliates, officers, directors, staff, or contractors. The author at the time of this article did not own any shares or receive any consideration financial or otherwise from any company or person mentioned or referred to in the article.

THIS IS NOT A RECOMMENDATION TO BUY OR SELL ANY SECURITY! Disclaimer: Never invest in any stock featured on our site or emails unless you can afford to lose your entire investment. CRWENewswire.com publisher and its affiliates and contractors are not registered investment advisers or broker/dealers. Our disclaimer is to be read and fully understood before using our site, reading our newsletter or joining our email list. Release of Liability: Through use of this website viewing or using, you agree to hold CRWENewswire.com report and Crown Equity Holdings, Inc. CRWE, its operators, shareholders, employees and/or contractors harmless and to completely release them from any and all liability due to any and all loss (monetary or otherwise), damages (monetary or otherwise) that you may occur. (read more) Rule 17B requires disclosure of payment for investor relations.

MusclePharm Corporation (OTCBB:MSLP), one of the fastest growing nutritional supplement companies in the United States with a proprietary formulation used in eight performance products, reports that MusclePharm athlete and NFL star Joey Porter will wear MusclePharm’s new clothing line during a 17-episode weekly series spanning the 2010 NFL season on NFL Network.

The new MusclePharm-branded hats and shirts will be unveiled to the retail market in the coming weeks and Porter’s notoriety in the world’s most popular sport presents an ideal platform to create exposure for the product line.

Consistently recognized as one of the most recognizable faces in the NFL thanks to his outgoing nature, Porter will be wearing MusclePharm apparel in all 17 episodes of a weekly NFL Network series that focuses on the upcoming NFL season.

The Arizona Cardinals and Super Bowl-winning linebacker is a 4-time Pro Bowler and was voted one of the top defensive players of the last decade. Porter has been an important MusclePharm spokesman due to his relentless playing style, tireless work ethic and outspoken personality, making this project a perfect way to reveal the new MusclePharm-branded apparel.

“At MusclePharm, we find creative ways to make our brand stand out to multiple audiences and in multiple formats to reach all consumers,” said Cory Gregory, MusclePharm’s President. “We currently have focused on brand awareness in marketing in the UFC, NFL, MLB and in action sports markets. We believe we are a company that crosses over to multiple demographics and helps all of these athletes in these different sports, while also appealing to the normal, everyday athlete.”

Nutrisystem, Inc. (Nasdaq:NTRI) is a leading provider of weight management products and services. Nutrisystem is sold direct to the consumer through nutrisystem.com, by phone, and at select retailers, with convenient home delivery. The Company offers proven nutritionally balanced weight loss programs designed for women, men, and seniors, as well as the clinically tested Nutrisystem D plan, designed to help people with type 2 diabetes who want to lose weight. The Nutrisystem program is based on more than 35 years of nutrition research and the science of the low glycemic index, and offers a variety of great tasting, satisfying high-fiber, good carbohydrate meals that are heart healthy. Nutrisystem was named the “Best Value” of the six most popular commercial diet programs by SmartMoney magazine in January 2010. The program has no membership fees and provides 24/7 weight management support by trained weight loss coaches and online weight management tools free of charge.

In spite of facing the deepest recession since the Great Depression and record unemployment rates, many Americans would pass up a work promotion to drop 10 to 20 pounds, according to the new Nutrisystem Diet Index issued by Nutrisystem, Inc., a leading provider of weight management programs and services. Americans would also rather give up sex than gain weight, and they’d toss their cell phones and give up watching TV to have a toned tummy, according to the new findings. The Nutrisystem Diet Index is a new series of national consumer surveys tracking America’s diet behaviors, attitudes and trends throughout the year. Each survey has a scale that measures America’s current diet and lifestyle behavior and choices.

“The fact of the matter is, America is obsessed with dieting and weight loss, but the majority of Americans aren’t eating healthier or getting thinner,” said Joe Redling, chairman and CEO of Nutrisystem, Inc. “We’ve developed the Nutrisystem Diet Index to better understand America’s attitudes toward dieting and to start a dialogue about healthy dieting and healthy lifestyle habits and trends.”

The first Nutrisystem Diet Index revealed that Americans place a high value on being healthy, but they abandon the idea of achieving a healthier weight and lifestyle, because they ultimately feel their goals are too difficult to attain and maintain. The American lifestyle is also a factor. Inconveniences of work, giving up favorite foods, not having the time to plan ahead, cooking for a larger family and the cost of healthy foods are cited as some of the biggest barriers.

USANA Health Sciences, Inc. (NASDAQ:USNA) has acquired BabyCare Ltd, a China-based direct selling company that develops, manufactures and sells nutritional products for the entire family, with an emphasis on infant nutrition. Founded in 1999, privately held BabyCare Ltd is headquartered in Beijing, China, with operations in 21 cities and 16 provinces. BabyCare’s products are sold through a growing distributor sales force, utilizing a commission-based compensation plan under a license to engage in direct selling activities in the Municipality of Beijing. BabyCare is working to obtain similar licenses in the other provinces in which it operates. This direct selling license allows BabyCare to engage non-employee distributors to sell BabyCare’s products, apart from the company’s traditional service centers.

The acquisition of BabyCare was accomplished by acquiring Pet Lane Inc., a Delaware corporation, who is the parent company of BabyCare in China. The transaction was entered into and closed according to the definitive terms of a share purchase agreement. The purchase price for the shares consisted of $45 million in cash and 400,000 shares of USANA stock. The details of the transaction will be filed shortly in Forms 8-K.

USANA Health Sciences, Inc. engages in the development, manufacture, and sale of nutritional and personal care products in North America and the Asia Pacific. The company offers two product lines, USANA Nutritionals and Sense. The USANA Nutritionals product line consists of essentials, which include vitamins and mineral supplements that provide a foundation of nutrition for various age groups; optimizers, which are targeted supplements that support cardiovascular health, skeletal/structural health, and digestive health; and macro-optimizers comprising low-glycemic meal replacement shakes, snack bars, and other related products that provide optimal macro-nutrition.

The Sense product line includes personal care products that support healthy skin and hair. These products include perfecting essence, gentle daily cleanser, hydrating toner, daytime protective emulsion, eye nourisher, night renewal, serum intensive, rice bran polisher, creme masque, revitalizing shampoo, nourishing conditioner, firming body nourisher, energizing shower gel, and intensive hand therapy.

THIS IS NOT A RECOMMENDATION TO BUY OR SELL ANY SECURITY!

Disclaimer: Never invest in any stock featured on our site or emails unless you can afford to lose your entire investment. BestOtc.com publisher and its affiliates and contractors are not registered investment advisers or broker/dealers.Our disclaimer ( http://bestotc.com/disclaimer) is to be read and fully understood before using our site, reading our newsletter or joining our email list. Release of Liability: Through use of this website viewing or using, you agree to hold BestOTC.com report and Crown Equity Holdings Inc. CRWE, its operators, shareholders, employees and/or contractors harmless and to completely release them from any and all liability due to any and all loss (monetary or otherwise), damages (monetary or otherwise) that you may occur. Rule 17B requires disclosure of payment for investor relations. Crown Equity Holdings Inc. (CRWE.OB) is a newswire as well as an IR and PR firm. Crown Equity Holdings Inc. (CRWE.OB), in some cases, provides media advertising and public awareness for both public and private companies, as well as disseminating news. As such, in some cases, when Crown Equity Holdings Inc. (CRWE.OB) advertises for a particular client, Crown Equity Holdings Inc. (CRWE.OB) charges an advertising fee which it must disclose under 17B. The fee may be in cash, in free trading stock or in restricted stock. Crown Equity Holdings Inc. (CRWE.OB), if paid in stock, can and may sell those securities during the advertising period. Crown Equity Holdings Inc. (CRWE.OB) has received twenty five thousand dollars in cash and seventy five thousand free trading shares from a third party (Bishop Equity Partners) for (30) days of advertising for Muscle Pharm Corp. (MSLP.OB).

Reported by: Emon CRWE Newswire Middle East correspondent.

As a result of the global financial crisis more than 30 million people worldwide have found themselves without work. This conclusion was made by experts of the International Monetary Fund (IMF) and International Labour Organization (ILO).

A joint report of the different organization including Voice of America stated that the total number of unemployed worldwide reached 210 million.

According to the IMF and the ILO, the crisis is particularly painful for countries with developed economies, and unemployment there remains high. But the crisis of 2007-2009, also affected the developing countries, increasing the number of people living below the poverty line. (which varies with each country)

The document’s authors urge all governments to continue efforts to increase domestic demand by stimulating their economies, and mitigate the damage caused by increasing unemployment benefits and programs on employment.

Unemployment among young people in the world reached record levels.
One of the side effects of unemployment is an increase in the rate and level of crime.

********************************************************************

The Views and Opinions Expressed by the author are his or her opinions only and do not necessarily reflect those of this Web-Site or its agents, affiliates, officers, directors, staff, or contractors. The author at the time of this article did not own any shares or receive any consideration financial or otherwise from any company or person mentioned or referred to in the article.

Reported by: Emon CRWE Newswire Middle East correspondent.

The world’s first solar-powered airplane called the “Solar Impulse” has recently finished a 24-hour test flight. The event took place in Switzerland.

During the day the airplane was at an altitude of 8 kilometers. The plane is charged by solar energy generated by solar panels, such panels had 11,628 solar cells. In the evening, when it was dark, the plane descended to a mile and continued its flight, which lasted 12 hours.

The company that developed the aircraft, this solar airplane, have decided to fly it around the world in 2012.

It weighs just 1600 kg with a wingspan of 63 meters; the plane captured the sun’s rays via 11,628 solar cells, each 150 microns thick, with 10,748 solar cells on the wings and 880 on the horizontal stabilizer. Energy was stored in lithium polymer batteries. The plane is capable of sustained air flight indefinitely

********************************************************************

The Views and Opinions Expressed by the author are his or her opinions only and do not necessarily reflect those of this Web-Site or its agents, affiliates, officers, directors, staff, or contractors. The author at the time of this article did not own any shares or receive any consideration financial or otherwise from any company or person mentioned or referred to in the article.

THIS IS NOT A RECOMMENDATION TO BUY OR SELL ANY SECURITY! Disclaimer: Never invest in any stock featured on our site or emails unless you can afford to lose your entire investment. CRWENewswire.com publisher and its affiliates and contractors are not registered investment advisers or broker/dealers. Our disclaimer is to be read and fully understood before using our site, reading our newsletter or joining our email list. Release of Liability: Through use of this website viewing or using, you agree to hold CRWENewswire.com report and Crown Equity Holdings, Inc. CRWE, its operators, shareholders, employees and/or contractors harmless and to completely release them from any and all liability due to any and all loss (monetary or otherwise), damages (monetary or otherwise) that you may occur. (read more) Rule 17B requires disclosure of payment for investor relations.